CoChat
Sign Up
Cited by 50

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells

Saint-Pol, Julien, Candela, Pietra, Boucau, Marie-Christine, Fenart, Laurence, Gosselet, Fabien·2013·Brain Research
DOI 10.1016/j.brainres.2013.04.008
Open this paper in CoChat — free account

Abstract

It is known that activation of the liver X receptors (LXRs) by natural or synthetic agonists decreases the amyloid burden and enhances cognitive function in transgenic murine models of Alzheimer's disease (AD). Recent evidence suggests that LXR activation may affect the transport of amyloid ß (Aß) peptides across the blood-brain barrier (the BBB, which isolates the brain from the peripheral circulation). By using a well-characterized in vitro BBB model, we demonstrated that LXR agonists (24S-hydroxycholesterol, 27-hydroxycholesterol and T0901317) modulated the expression of target genes involved in cholesterol homeostasis (such as ATP-binding cassette sub-family A member 1 (ABCA1)) and promoted cellular cholesterol efflux to apolipoprotein A-I and high density lipoproteins. Interestingly, we also observed a decrease in Aß peptide influx across brain capillary endothelial cells, although ABCA1 did not appear to be directly involved in this process. By focusing on others receptors and transporters that are thought to have major roles in Aß peptide entry into the brain, we then demonstrated that LXR stimulation provoked an increase in expression of the ABCB1 transporter (also named P-glycoprotein (P-gp)). Further investigations confirmed ABCB1's involvement in the restriction of Aß peptide influx. Taken as a whole, our results not only reinforce the BBB's key role in cerebral cholesterol homeostasis but also demonstrate the importance of the LXR/ABCB1 axis in Aß peptide influx-h…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2013.04.008

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 63

  1. Abbott, 2010, Structure and function of the blood-brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030 · DOI · Paper page
  2. Abildayeva, 2006, 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux, J. Biol. Chem., 281, 12799, 10.1074/jbc.M601019200 · DOI · Paper page
  3. Akanuma, 2008, Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood-brain barrier, Neurochem. Int., 52, 669, 10.1016/j.neuint.2007.08.012 · DOI · Paper page
  4. Akanuma, 2008, ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1-40) at the blood-brain barrier, Neurochem. Int., 52, 956, 10.1016/j.neuint.2007.12.002 · DOI · Paper page
  5. Balayssac, 2005, Does inhibition of P-glycoprotein lead to drug–drug interactions?, Toxicol. Lett., 156, 319, 10.1016/j.toxlet.2004.12.008 · DOI
  6. Bjorkhem, 1999, Removal of cholesterol from extrahepatic sources by oxidative mechanisms, Curr. Opin. Lipidol., 10, 161, 10.1097/00041433-199904000-00010 · DOI
  7. Bjorkhem, 2006, Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain, J. Intern. Med., 260, 493, 10.1111/j.1365-2796.2006.01725.x · DOI
  8. Brillault, 2002, Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the blood-brain barrier during ischaemia, J. Neurochem., 83, 807, 10.1046/j.1471-4159.2002.01186.x · DOI
  9. Burns, 2006, The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo, J. Neurochem., 98, 792, 10.1111/j.1471-4159.2006.03925.x · DOI · Paper page
  10. Candela, 2010, Apical-to-basolateral transport of amyloid-beta peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein, J. Alzheimer's Dis.: JAD, 22, 849, 10.3233/JAD-2010-100462 · DOI · Paper page
  11. Cecchelli, 1999, In vitro model for evaluating drug transport across the blood-brain barrier, Adv. Drug Delivery Rev., 36, 165, 10.1016/S0169-409X(98)00083-0 · DOI
  12. Cecchelli, 2007, Modelling of the blood-brain barrier in drug discovery and development. Nature reviews, Drug Discovery, 6, 650, 10.1038/nrd2368 · DOI
  13. Chobanian, 1962, Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol, J. Clin. Invest., 41, 1732, 10.1172/JCI104631 · DOI
  14. Culot, 2008, An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening, Toxicol. In Vitro: Int. J. Publ. Assoc. BIBRA, 22, 799, 10.1016/j.tiv.2007.12.016 · DOI
  15. de Vries, 2007, P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 13, 6440, 10.1158/1078-0432.CCR-07-1335 · DOI
  16. Deane, 2012, A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease, J. Clin. Invest., 122, 1377, 10.1172/JCI58642 · DOI · Paper page
  17. Decleves, 2006, Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions?, Toxicol. Appl. Pharmacol., 217, 153, 10.1016/j.taap.2006.08.004 · DOI
  18. Dehouck, 1997, A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier, J. Cell Biol., 138, 877, 10.1083/jcb.138.4.877 · DOI · Paper page
  19. Dehouck, 1990, An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro, J. Neurochem., 54, 1798, 10.1111/j.1471-4159.1990.tb01236.x · DOI
  20. Dehouck, 1992, Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models, J. Neurochem., 58, 1790, 10.1111/j.1471-4159.1992.tb10055.x · DOI
  21. Do, 2011, Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood-brain barrier, Mol. Cell. Biochem., 357, 397, 10.1007/s11010-011-0910-6 · DOI · Paper page
  22. Donkin, 2010, ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice, J. Biol. Chem., 285, 34144, 10.1074/jbc.M110.108100 · DOI · Paper page
  23. Elali, 2012, Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells, Brain Pathol., 22, 175, 10.1111/j.1750-3639.2011.00517.x · DOI · Paper page
  24. Favari, 2004, Probucol inhibits ABCA1-mediated cellular lipid efflux, Arteriosclerosis, Thromb. Vasc. Biol., 24, 2345, 10.1161/01.ATV.0000148706.15947.8a · DOI
  25. Fenart, 1998, Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier, Pharm. Res., 15, 993, 10.1023/A:1011913723928 · DOI
  26. Fitz, 2010, Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice, J. Neurosci.: Off. J. Soc. Neurosci., 30, 6862, 10.1523/JNEUROSCI.1051-10.2010 · DOI · Paper page
  27. Fitz, 2012, Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice, J. Neurosci.: Off. J. Soc. Neurosci., 32, 13125, 10.1523/JNEUROSCI.1937-12.2012 · DOI · Paper page
  28. Fujiyoshi, 2007, 24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression, J. Neurochem., 100, 968, 10.1111/j.1471-4159.2006.04240.x · DOI · Paper page
  29. Gosselet, 2009, Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model, Brain Res., 1249, 34, 10.1016/j.brainres.2008.10.036 · DOI
  30. Hallier-Vanuxeem, 2009, New strategy for alerting central nervous system toxicity: integration of blood-brain barrier toxicity and permeability in neurotoxicity assessment, Toxicol. In Vitro: Int. J. Publ. Assoc. BIBRA, 23, 447, 10.1016/j.tiv.2008.12.011 · DOI
  31. Hartz, 2010, Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease, Mol. Pharmacol., 77, 715, 10.1124/mol.109.061754 · DOI
  32. Karasinska, 2009, Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function, J. Neurosci.: Off. J. Soc. Neurosci., 29, 3579, 10.1523/JNEUROSCI.4741-08.2009 · DOI · Paper page
  33. Kim, 2008, Role of ATP-binding cassette transporters in brain lipid transport and neurological disease, J. Neurochem., 104, 1145, 10.1111/j.1471-4159.2007.05099.x · DOI
  34. Kolsch, 2001, Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta, J. Neural Transm., 108, 475, 10.1007/s007020170068 · DOI
  35. Krohn, 2011, Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice, J. Clin. Invest., 121, 3924, 10.1172/JCI57867 · DOI · Paper page
  36. Kuhnke, 2007, MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides—implications for the mechanisms of Abeta clearance at the blood-brain barrier, Brain Pathol., 17, 347, 10.1111/j.1750-3639.2007.00075.x · DOI
  37. Langmann, 2006, Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation, Clin. Chem., 52, 310, 10.1373/clinchem.2005.059774 · DOI · Paper page
  38. Leoni, 2003, Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers, J. Lipid Res., 44, 793, 10.1194/jlr.M200434-JLR200 · DOI
  39. Lutjohann, 1996, Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation, Proc. Natl. Acad. Sci. USA, 93, 9799, 10.1073/pnas.93.18.9799 · DOI · Paper page
  40. Meaney, 2002, On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function, J. Lipid Res., 43, 2130, 10.1194/jlr.M200293-JLR200 · DOI
  41. Osono, 1995, Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse, J. Clin. Invest., 95, 1124, 10.1172/JCI117760 · DOI · Paper page
  42. Panzenboeck, 2002, ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells, J. Biol. Chem., 277, 42781, 10.1074/jbc.M207601200 · DOI · Paper page
  43. Panzenboeck, 2006, Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells, Int. J. Biochem. Cell Biol., 38, 1314, 10.1016/j.biocel.2006.01.013 · DOI
  44. Pfrieger, 2003, Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? BioEssays: news and reviews in molecular, Cell. Dev. Biol., 25, 72
  45. Qosa, 2012, Enhanced brain amyloid-beta clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease, J. Alzheimer's Dis.: JAD, 31, 151, 10.3233/JAD-2012-120319 · DOI
  46. Querfurth, 2010, Alzheimer's disease, N. Engl. J. Med., 362, 329, 10.1056/NEJMra0909142 · DOI · Paper page
  47. Repa, 2000, Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta, Genes Dev., 14, 2819, 10.1101/gad.844900 · DOI
  48. Riendeau, 2009, Effect of 27-hydroxycholesterol on survival and death of human macrophages and vascular smooth muscle cells, Free Radical Res., 43, 1019, 10.1080/10715760903040610 · DOI
  49. Saint-Pol, 2012, Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-beta peptide accumulation, J. Alzheimer's Dis.: JAD, 30, 489, 10.3233/JAD-2012-112090 · DOI · Paper page
  50. Spady, 1987, Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit, J. Lipid Res., 28, 32, 10.1016/S0022-2275(20)38731-9 · DOI
  51. Stefulj, 2009, Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1, Circ. Res., 104, 600, 10.1161/CIRCRESAHA.108.185066 · DOI
  52. Tai, 2009, P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta, J. Cereb. Blood Flow and Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab., 29, 1079, 10.1038/jcbfm.2009.42 · DOI · Paper page
  53. Tai, 2009, Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123, Brain Res., 1292, 14, 10.1016/j.brainres.2009.07.039 · DOI
  54. van Assema, 2012, P-glycoprotein function at the blood-brain barrier: effects of age and gender, Mol. Imaging Biol.: MIB: Off. Publ. Acad. Mol. Imaging, 14, 771, 10.1007/s11307-012-0556-0 · DOI
  55. Vaya, 2007, Oxysterols, cholesterol homeostasis, and Alzheimer disease, J. Neurochem., 102, 1727, 10.1111/j.1471-4159.2007.04689.x · DOI
  56. Vogelgesang, 2002, Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans, Pharmacogenetics, 12, 535, 10.1097/00008571-200210000-00005 · DOI
  57. Wahrle, 2005, Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease, J. Biol. Chem., 280, 43236, 10.1074/jbc.M508780200 · DOI · Paper page
  58. Whitney, 2002, Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system, Mol. Endocrinol., 16, 1378, 10.1210/mend.16.6.0835 · DOI · Paper page
  59. Wijesuriya, 2010, ABC efflux transporters in brain vasculature of Alzheimer's subjects, Brain Res., 1358, 228, 10.1016/j.brainres.2010.08.034 · DOI
  60. Wilson, 1970, The measurement of the exchangeable pools of cholesterol in the baboon, J. Clin. Invest., 49, 655, 10.1172/JCI106277 · DOI
  61. Wong, 2006, SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR, Biochem. J., 400, 485, 10.1042/BJ20060914 · DOI · Paper page
  62. Zelcer, 2007, Attenuation of neuroinflammation and Alzheimer's disease pathology by liver×receptors, Proc. Natl. Acad. Sci. USA, 104, 10601, 10.1073/pnas.0701096104 · DOI · Paper page
  63. Zlokovic, 2008, The blood-brain barrier in health and chronic neurodegenerative disorders, Neuron, 57, 178, 10.1016/j.neuron.2008.01.003 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Saint-Pol, J., Candela, P., Boucau, M.-C., Fenart, L., & Gosselet, F.
Venue
Brain Research
Publisher
Elsevier BV
Published
2013-06
Volume
1517
Pages
1-15
ISSN
0006-8993
DOI
10.1016/j.brainres.2013.04.008
Cited by
50
References
11
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Coeur & Artères foundation (06T6)
  • LECMA (09752)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review